Avinger Inc shares soared 72.16% during the trading hours and continued to gain 13.21% in extended trading on Tuesday, adding to outsized gains from Monday. Here's a look at what's going on.
What To Know: On Monday, Avinger shares soared 46.8% to $6.07 after the company announced the commercial launch of its Tigereye ST image-guided CTO crossing device.
The commercial-stage medical device company said it conducted a limited launch prior to commercialization that showed successful implementation of new design features, safety, efficacy and product reliability.
"This device represents one of the most significant advancements in Avinger's image-guided technologies for the treatment of peripheral artery disease," said Jaafer Golzar, chief medical officer of Avinger.
After the close on Monday, a new regulatory filing showed that Avinger decided to increase the available amount for sale under its previously disclosed at the market offering up to an additional aggregate offering price of $2,133,181.
Avinger shares are moving on very high volume. The stock has been trending across social platforms this week. It was among the top trending tickers on Stocktwits at last check.